Search

everythinglearnresearchcommunity

for

Search:↓

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

TNF-${\alpha}$ slows hair growth, and minoxidil doesn't help.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

The document discusses new insights into how hormones affect male sexual health and related conditions.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Different genes are linked to various types of hair loss.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.